Clinical Trial Update: Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma". Descriptive Pilot Study [NA]

View source ↗

Summary

The document reports a completed descriptive pilot study evaluating dermo-cosmetic products to treat skin and nail toxicity in multiple myeloma patients treated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bispecific anti-GPRC5D antibodies

Snippet

Sponsor: Nantes University Hospital | Conditions: Myeloma Multiple | NA | Status: COMPLETED